NYSE:DOCSHealthcare Services
Doximity (DOCS) Is Down 9.8% After New AI Spend, Buyback Plan And Guidance Update – Has The Bull Case Changed?
In early February 2026, Doximity reported third‑quarter 2025 results showing sales of US$185.05 million and net income of US$61.56 million, updated full‑year revenue guidance to about US$642.5–643.5 million, and authorized a new US$500 million share repurchase program after completing a prior US$417.04 million buyback.
While revenue and nine‑month earnings rose year over year, quarterly profit per share dipped as management cited delayed pharmaceutical budgets and higher AI infrastructure...